AI Assistant
Blog
Pricing
Log In
Sign Up
High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML – YES
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
